Certified by Founder
Lodge
Mercy BioAnalytics, Inc.
start up
United States
- Natick, Massachusetts
- 04/04/2023
- Series A
- $41,000,000
Mercy BioAnalytics is on a mission to save lives and relieve suffering across the globe through the early detection of cancer. We have developed a novel liquid biopsy assay platform which interrogates tumor-derived extracellular vesicles, which are abundant in blood and carry information about their cell of origin, enabling detection of cancer even in at the earliest stages.
- Industry Biotechnology Research
- Website https://mercybio.com/
- LinkedIn https://www.linkedin.com/company/mercy-bioanalytics/
Related People
Dawn MattoonFounder
United States -
Natick, Massachusetts
Seasoned biotech leader with a passion for developing and commercializing impactful, innovative new products and developing high performing teams.
Ricursive Intelligence | $300,000,000 | (Jan 28, 2026)
Nerd Apply | $3,200,000 | (Jan 28, 2026)
Fiddler AI | $30,000,000 | (Jan 28, 2026)
Jelou AI | $10,000,000 | (Jan 28, 2026)
Concourse | $12,000,000 | (Jan 28, 2026)
Risotto | $10,000,000 | (Jan 28, 2026)
Summize | $50,000,000 | (Jan 28, 2026)
FLORA(US) | $42,000,000 | (Jan 28, 2026)
Fortitude Biomedicines | $13,000,000 | (Jan 28, 2026)
Chamelio | $10,000,000 | (Jan 28, 2026)
Opendate | $14,000,000 | (Jan 28, 2026)
Memcyco | $37,000,000 | (Jan 28, 2026)
Midship | $4,150,000 | (Jan 28, 2026)